Carpal Tunnel Syndrome, Suture, Complication, Wound Infection
Conditions
Keywords
carpal tunnel syndrome, wound infection, absorbable sutures, non-absorbable sutures
Brief summary
Carpal Tunnel Syndrome is a prevalent condition, up to 9% in women and 0.6% in men. Surgical decompression in the most effective treatment. After surgery, approximately 1,8% of the patients develop a wound infection. Possibly, the type of sutures used can influence the prevalence of wound infection. In this RCT the incidence of infection is investigated between the use of absorbable versus non-absorbable sutures in carpal tunnel release.
Detailed description
Carpal Tunnel Syndrome is a prevalent condition; up to 9% in women and 0.6% in men. It causes complaints of paresthesia, pain, numbness and loss of strength. Surgical decompression is the most effective treatment. After surgery, approximately 1,8% of the patients develop a wound infection. Possibly, the type of suture material which is used can influence the prevalence of wound infection. In current clinical practice both absorbable and non absorbable sutures are used. In literature, various hypothesis are described: Absorbable sutures could give more reaction of macrophages and therefore a higher chance on infection. This would not be the case for non-absorbable sutures, since they will be removed. However, in literature, there is still not enough evidence for superiority of absorbable or non-absorbable suture. In this RCT the incidence of infection is investigated between the use of absorbable versus non-absorbable sutures in carpal tunnel release. The primary outcome is the ASEPSIS wound score. This will be scored by independent investigators. Use of antibiotics, handtherapy and extra outpatient visits will be recorded. Patients are asked to register their NRS scores the first three weeks after surgery.
Interventions
PROCEDURECarpal Tunnel Release
Transection of flexor retinaculum for patients who have carpal tunnel syndrome
Sponsors
Deventer Ziekenhuis
Gelre Hospitals
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
• indication for carpal tunnel release
Exclusion criteria
* carpal tunnel syndrome which has yet been operated * injection with corticosteroids
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| ASEPSIS wound score (Additional treatment, Serous discharge, Erythema, Purulent exudate, Separation of deep tissues, Isolation of bacteria, and Stay as inpatient prolonged over 14 days) | 10 to 14 days post surgery | score based on a picture made of the wound 10-14 days post carpal tunnel release. Minimum score 0, maximum score 70, score above 40 is categorized as wound infection |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| NRS score (Numeric Rating Scale for pain) | until three weeks post surgery | pain score, minimum score 0, maximum score 10. Unbearable pain is scored as 10, no pain is scored as 0. |
Countries
Netherlands
Contacts
Primary ContactPauline Verhaegen, MD PHD
Outcome results
None listed